Study links heartburn drugs to higher heart attack risk
The study in the journal PLOS ONE was based on a large data-mining study of nearly three million health records, and was carried out by scientists at Stanford University.
The study looked at drugs like Prilosec, Nexium and Prevacid, which are part of a class of drugs known as proton-pump inhibitors, or PPIs, and are among the world's most widely prescribed drugs, generating some $14bn in annual sales.
About 20 million Americans, or one in every 14 people, use PPIs such as Prilosec (omeprazole) for heartburn, acid reflux or gastroesophageal reflux disease, according to the study.
Until now, they were largely considered to be safe unless taken with the blood thinner Plavix (clopidogrel).
While the study did not prove that antacids cause heart attacks - only that there is an apparent link - researchers believe the problem may involve how the drugs affect the lining of blood vessels.
Another kind of antacid, known as H2 blockers, showed no higher risk of heart attack. These drugs include Zantac and Tagamet.
Researchers urged patients to talk with their doctors before discontinuing any medication.
Source: AFP
Source: I-Net Bridge
For more than two decades, I-Net Bridge has been one of South Africa’s preferred electronic providers of innovative solutions, data of the highest calibre, reliable platforms and excellent supporting systems. Our products include workstations, web applications and data feeds packaged with in-depth news and powerful analytical tools empowering clients to make meaningful decisions.
We pride ourselves on our wide variety of in-house skills, encompassing multiple platforms and applications. These skills enable us to not only function as a first class facility, but also design, implement and support all our client needs at a level that confirms I-Net Bridge a leader in its field.
Go to: http://www.inet.co.za